In The News: June 2011

A new study shows that systemic inflammation may contribute to the progression of atherosclerosis-the buildup of plaque in artery walls-in people with rheumatoid arthritis (RA). The data, released during a recent meeting of the American College of Rheumatology, also shows that the progression may be modified favorably by TNF inhibitors and adversely by glucocorticoids. The increased incidence of atherosclerosis in RA patients is known. However, few studies have explored the predictors of atherosclerosis change in RA patients.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access